BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28685716)

  • 1. Gene Variations of Sixth Complement Component Affecting Tacrolimus Metabolism in Patients with Liver Transplantation for Hepatocellular Carcinoma.
    Liao JH; Li CC; Wu SH; Fan JW; Gu HT; Wang ZW
    Chin Med J (Engl); 2017 Jul; 130(14):1670-1676. PubMed ID: 28685716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel single nucleotide polymorphisms in interleukin 6 affect tacrolimus metabolism in liver transplant patients.
    Chen D; Fan J; Guo F; Qin S; Wang Z; Peng Z
    PLoS One; 2013; 8(8):e73405. PubMed ID: 23991193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recipient C6 rs9200 genotype is associated with hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.
    Wang Z; Liao J; Wu S; Li C; Fan J; Peng Z
    Cancer Gene Ther; 2016 Jun; 23(6):157-61. PubMed ID: 27173880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of recipient SLCO1B1 rs2291075 polymorphism on tacrolimus dose-corrected trough concentration in the early period after liver transplantation.
    Wu Y; Fang F; Wang Z; Wen P; Fan J
    Eur J Clin Pharmacol; 2021 Jun; 77(6):859-867. PubMed ID: 33386894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of donor small ubiquitin-like modifier 4 rs237025 genetic variant with tacrolimus elimination in the early period after liver transplantation.
    Zhang T; Liu Y; Zeng R; Ling Q; Wen P; Fan J; Peng Z
    Liver Int; 2018 Apr; 38(4):724-732. PubMed ID: 28941036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP3A7, CYP3A4, and CYP3A5 genetic polymorphisms in recipients rather than donors influence tacrolimus concentrations in the early stages after liver transplantation.
    Dong Y; Xu Q; Li R; Tao Y; Zhang Q; Li J; Ma Z; Shen C; Zhong M; Wang Z; Qiu X
    Gene; 2022 Jan; 809():146007. PubMed ID: 34688813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of TLR4 rs1927907 locus polymorphisms on tacrolimus pharmacokinetics in the early stage after liver transplantation.
    Wang Z; Wu S; Chen D; Guo F; Zhong L; Fan J; Peng Z
    Eur J Clin Pharmacol; 2014 Aug; 70(8):925-31. PubMed ID: 24820765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR9 rs352139 Genetic Variant Promotes Tacrolimus Elimination in Chinese Liver Transplant Patients During the Early Posttransplantation Period.
    Ou B; Liu Y; Zhang T; Sun Y; Chen J; Peng Z
    Pharmacotherapy; 2019 Jan; 39(1):67-76. PubMed ID: 30537010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor and recipient P450 gene polymorphisms influence individual pharmacological effects of tacrolimus in Chinese liver transplantation patients.
    Liu J; Ouyang Y; Chen D; Yao B; Lin D; Li Z; Zang Y; Liu H; Fu X
    Int Immunopharmacol; 2018 Apr; 57():18-24. PubMed ID: 29454235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recipient C7 rs9292795 genotype and the risk of hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.
    Jiang Z; Jiang Q; Fang X; Wang P; Que W; Li H; Yu Y; Liu X; Wang C; Zhong L
    BMC Cancer; 2021 May; 21(1):521. PubMed ID: 33964921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver Transplant Patient Carriers of Polymorphism Cyp3a5*1 Donors May Need More Doses of Tacrolimus From the First Month After Transplantation.
    Argudo A; González de Aledo JM; Alía P; Ramírez P; Serrano T; Fabregat J; Castellote J
    Transplant Proc; 2015 Oct; 47(8):2388-92. PubMed ID: 26518936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of
    Nakamura T; Fukuda M; Matsukane R; Suetsugu K; Harada N; Yoshizumi T; Egashira N; Mori M; Masuda S
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32225074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Influence of CYP3A5 Gene Polymorphism on Pharmacokinetics of Tacrolimus and Patient Outcome After Living Donor Liver Transplantation.
    Kato H; Usui M; Muraki Y; Tanemura A; Murata Y; Kuriyama N; Azumi Y; Kishiwada M; Mizuno S; Sakurai H; Okuda M; Nakatani K; Isaji S
    Transplant Proc; 2016 May; 48(4):1087-94. PubMed ID: 27320564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of a Once-Daily Dose of Tacrolimus Early After Liver Transplantation: With Special Reference to CYP3A5 and ABCB1 Single Nucleotide Polymorphisms.
    Miyata Y; Akamatsu N; Sugawara Y; Kaneko J; Yamamoto T; Suzuki H; Arita J; Sakamoto Y; Hasegawa K; Tamura S; Kokudo N
    Ann Transplant; 2016 Aug; 21():491-9. PubMed ID: 27503662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of Wuzhi Capsule on tacrolimus blood concentrations in liver transplant patients with different donor-recipient CYP3A5 genotypes.
    Kou K; Sun X; Li M; Li T; Hu Y; Li S; Lv G
    J Clin Pharm Ther; 2022 Feb; 47(2):200-210. PubMed ID: 34708436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of CYP3A4, CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics and early renal dysfunction in liver transplant recipients.
    Shi Y; Li Y; Tang J; Zhang J; Zou Y; Cai B; Wang L
    Gene; 2013 Jan; 512(2):226-31. PubMed ID: 23107770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of donor-recipient combinational CYP3A5 genotypes on tacrolimus dosing in Chinese DDLT adult recipients.
    Liu J; Chen D; Yao B; Guan G; Liu C; Jin X; Wang X; Liu P; Sun Y; Zang Y
    Int Immunopharmacol; 2020 Mar; 80():106188. PubMed ID: 31931373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of cytochrome P450 3A5 polymorphism in graft livers on the frequency of acute cellular rejection in living-donor liver transplantation.
    Uesugi M; Kikuchi M; Shinke H; Omura T; Yonezawa A; Matsubara K; Fujimoto Y; Okamoto S; Kaido T; Uemoto S; Masuda S
    Pharmacogenet Genomics; 2014 Jul; 24(7):356-66. PubMed ID: 24911663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of CYP3A5 gene polymorphisms on tacrolimus concentration/dosage ratio in adult liver transplant patients.
    Wang L; Liu LH; Tong WH; Wang MX; Lu SC
    Genet Mol Res; 2015 Nov; 14(4):15148-57. PubMed ID: 26634478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP3A5*1-carrying graft liver reduces the concentration/oral dose ratio of tacrolimus in recipients of living-donor liver transplantation.
    Goto M; Masuda S; Kiuchi T; Ogura Y; Oike F; Okuda M; Tanaka K; Inui K
    Pharmacogenetics; 2004 Jul; 14(7):471-8. PubMed ID: 15226679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.